Global Wealth Strategies & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-135
Closed -$47.7K 114
2026
Q1
$47.7K Hold
135
0.01% 174
2025
Q4
$44.3K Sell
135
-18
-12% -$5.71K 0.01% 164
2025
Q3
$43.3K Buy
153
+19
+14% +$5.51K 0.01% 158
2025
Q2
$37.4K Hold
134
0.01% 127
2025
Q1
$41.7K Buy
134
+125
+1,389% +$36.9K 0.01% 135
2024
Q4
$2.35K Hold
9
﹤0.01% 313
2024
Q3
$2.9K Buy
+9
New +$2.94K ﹤0.01% 277
2023
Q2
Sell
-7
Closed -$1.69K 329
2023
Q1
$1.69K Hold
7
﹤0.01% 277
2022
Q4
$1.84K Buy
+7
New +$1.88K ﹤0.01% 272

Other funds holding AMGN

Global Wealth Strategies & Associates's AMGN Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Amgen (AMGN) in Q2 2026, closing a stake of 135 shares — an estimated $47.7K sold.

Global Wealth Strategies & Associates first reported a position in AMGN in Q4 2022 and held it in 9 quarters. The position peaked at $47.7K in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 135 Amgen shares in Q2 2026, an estimated $47.7K.
  • Global Wealth Strategies & Associates first reported a position in Amgen in Q4 2022 and held it in 9 quarters.
  • Global Wealth Strategies & Associates's Amgen position peaked at $47.7K in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.